Naluri, which has a Malaysian subsidiary, obtained the US$7 million (RM30.78 million) in a pre “Series B” funding round, led by Pruksa Group, Thailand’s leading real estate development group, which is also involved in the digital health technology and healthcare operations through Vimut Hospitals.

Pruksa Group is joined by Bertelsmann Investments from Germany and Striders Corporation from Japan and is supported by several returning investors, including M Venture Partners (MVP), Palm Drive Capital, and INP Capital.

Co-founded by entrepreneur Azran Osman-Rani, its Malaysian unit Naluri Hidup Sdn Bhd secured US$5 million (RM21.99 million) through a Series A round of funding, with cornerstone investment by Singapore’s Integra Partners, and returning strategic investors, Duopharma Biotech Berhad, Pathology Asia (via Biomark), and venture capital firm, M Venture Partners, in June last year.

Naluri pairs evidence-based interventions and human-led expertise with a digital platform (via the Naluri app) to deliver significant health outcomes at a lower cost to healthcare payers.

In regions where shortages of registered professionals constrain care delivery, Naluri empowers its team of health and wellness experts with data and the company’s proprietary AI-augmented coaching platform, decision support systems and self-help digital tools.

It offers healthcare payers effective corporate wellness solutions across Malaysia, Singapore, Thailand and Indonesia, with imminent plans for expansion into the Philippines, Hong Kong and Australia.